Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc.

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

Discover top medications for 'treating Parkinsons Disease'? This page compiles essential information on generic and brand-name drugs specifically used for Parkinsons Disease treatment.Here ...

WEHI researchers have solved a decades-long mystery by determining the structure of human PINK1, a key protein linked to ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

They treated flies with the drug IU1 ... advances in anti-aging therapy. "Reduced protein homeostasis is a major characteristic of degenerative diseases such as Alzheimer's and Parkinson's disease.

Denmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the clinic – a human antibody that the company hopes will tackle the underlying cause of the condition.

Pioneering Cancer TreatmentAnti-tumor Active Pharmaceutical Ingredients (APIs) are vital in today's medical landscape, addressing one of the most pressing health challenges: cancer. These APIs form ...